Christopher Viehbacher

Christopher Viehbacher

Chief Executive Officer chez BIOGEN INC.

Fortune : 2 M $ au 31/03/2024

64 ans
Health Technology
Commercial Services
Consumer Services

Sociétés liées

Sociétés cotées6
PFIZER, INC.

Health Technology

BIOGEN INC.

Health Technology

SANOFI

Health Technology

AXCA HEALPAR

Health Technology

GSK PLC

Health Technology

PURETECH HEALTH PLC

Health Technology

Entreprise privées24
Glaxo Wellcome Plc

Health Technology

Commercial Services

Commercial Services

Health Technology

Miscellaneous

Commercial Services

Commercial Services

Health Technology

Health Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

The International Business Council

Retail Trade

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Finance

Voir les connexions sociétés

Formation de Christopher Viehbacher

Queen's University Undergraduate Degree